Castleark Management LLC Ptc Therapeutics, Inc. Transaction History

Castleark Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$35.42 - $45.0 $3.33 Million - $4.23 Million	-94,102 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$28.09 - $39.49 $44,747 - $62,907	-1,593 Reduced 1.66%	94,102 $3.54 Million
Q4 2018 Feb 12, 2019	SELL	$29.83 - $46.51 $2.21 Million - $3.45 Million	-74,225 Reduced 43.68%	95,695 $3.28 Million
Q3 2018 Nov 15, 2018	BUY	$33.9 - $47.77 $5.76 Million - $8.12 Million	169,920 New	169,920 $7.99 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.